-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Certepetide in Gallbladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Certepetide in Gallbladder Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Certepetide in Gallbladder Cancer Drug Details: Certepetide (CEND-1) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OLX-301A in Geographic Atrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OLX-301A in Geographic Atrophy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OLX-301A in Geographic Atrophy Drug Details: OLX-301A is under development for the...
-
Product Insights
NewHospital Acquired Pneumonia (HAP) – Drugs In Development, 2024
Empower your strategies with our Hospital Acquired Pneumonia (HAP) – Drugs In Development, 2024 report and make more profitable business decisions. Hospital-acquired pneumonia (HAP) is defined as pneumonia acquired during a hospital stay. Symptoms include cough, fever, shaking chills, confusion, headache, and loss of appetite. Risk factors include chronic lung disease, cigarette smoking, dementia, stroke, brain injury, heart disease, liver cirrhosis, and diabetes mellitus. Treatment includes antibiotics and healthy lifestyle. The Hospital Acquired Pneumonia (HAP) drugs in development market research report...
-
Product Insights
NewUreter Cancer – Drugs In Development, 2024
Empower your strategies with our Ureter Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Ureter cancer or ureteral cancer is cancer of the ureter. Symptoms and signs of urethral cancer include bleeding from the urethra or blood in the urine, discharge from the urethra, and enlarged lymph nodes in the groin area. Risk factors include smoking. Treatment includes surgery, chemotherapy, and radiation therapy. The Ureter Cancer drugs in development market research report provide comprehensive information on...
-
Product Insights
NewUrethral Cancer – Drugs In Development, 2024
Empower your strategies with our Urethral Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Urethral cancer is a condition in which cancerous (malignant) cells form tumors in the tissues of urethra. Urethra is the tube through which urine flows out of the bladder. A history of bladder cancer can affect the risk of urethral cancer and it occurs more often in men than in women. The symptoms include blood in urine, discharge or bleeding from the...
-
Product Insights
NewVentilator Associated Pneumonia (VAP) – Drugs In Development, 2024
Empower your strategies with our Ventilator Associated Pneumonia (VAP) – Drugs In Development, 2024 report and make more profitable business decisions. Ventilator-associated pneumonia (VAP) is pneumonia that develops 48 hours or longer after mechanical ventilation is given by means of an endotracheal tube or tracheostomy. Ventilator-associated pneumonia (VAP) results from the invasion of the lower respiratory tract and lung parenchyma by microorganisms. The most important signs are fever, low body temperature, new purulent sputum, and hypoxemia (decreasing amounts of oxygen in...
-
Product Insights
NewGouty Arthritis (Gout) – Drugs In Development, 2024
Empower your strategies with our Gouty Arthritis (Gout) – Drugs In Development, 2024 report and make more profitable business decisions. Gout is a type of arthritis where swelling and severe pain develops in joints, especially at the base of the big toe. Gout occurs when uric acid builds up in the blood and causes inflammation in the joints. Symptoms include sudden onset of joint pain, joint swelling, heat in the affected area, and joint redness. Risk factors include obesity, high alcohol...
-
Product Insights
NewMusculoskeletal Inflammation – Drugs In Development, 2024
Empower your strategies with our Musculoskeletal Inflammation – Drugs In Development, 2024 report and make more profitable business decisions. Musculoskeletal inflammation refers to the body's response to irritation, injury, or infection affecting muscles, bones, joints, ligaments, or tendons. Conditions like arthritis, tendinitis, bursitis, or muscle strains often trigger this response. Inflammation manifests as pain, swelling, stiffness, and reduced mobility in the affected area. Causes vary—from overuse or trauma to autoimmune disorders like rheumatoid arthritis. Treatment aims to reduce inflammation and manage...